139 related articles for article (PubMed ID: 42434)
21. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
[TBL] [Abstract][Full Text] [Related]
22. Analysis of electrostatic interactions and their relationship to conformation and stability of bovine pancreatic trypsin inhibitor.
March KL; Maskalick DG; England RD; Friend SH; Gurd FR
Biochemistry; 1982 Oct; 21(21):5241-51. PubMed ID: 7171553
[TBL] [Abstract][Full Text] [Related]
23. Trypsin-pancreatic secretory isoinhibitor A from bovine pancreas (Kazal type). Spectroscopic study on structure and stability.
Menegatti E; Salvadori S; Guarneri M; Scatturin A
Int J Pept Protein Res; 1983 May; 21(5):562-7. PubMed ID: 6885242
[TBL] [Abstract][Full Text] [Related]
24. [Determination and comparative analysis of the conformation of bovine pancreatic trypsin inhibitor and trypsin inhibitors E and K from the data of two-dimensional 1H-NMR spectroscopy].
Sherman SA; Andrianov AM
Mol Biol (Mosk); 1985; 19(5):1301-9. PubMed ID: 4079926
[TBL] [Abstract][Full Text] [Related]
25. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region.
Rühlmann A; Kukla D; Schwager P; Bartels K; Huber R
J Mol Biol; 1973 Jul; 77(3):417-36. PubMed ID: 4737866
[No Abstract] [Full Text] [Related]
26. pH and temperature effects on the molecular conformation of the porcine pancreatic secretory trypsin inhibitor as detected by hydrogen-1 nuclear magnetic resonance.
De Marco A; Menegatti E; Guarneri M
Biochemistry; 1982 Jan; 21(2):222-9. PubMed ID: 6803827
[TBL] [Abstract][Full Text] [Related]
27. Water catalysis of peptide hydrogen isotope exchange.
Gregory RB; Crabo L; Percy AJ; Rosenberg A
Biochemistry; 1983 Feb; 22(4):910-7. PubMed ID: 6838830
[TBL] [Abstract][Full Text] [Related]
28. Trypsin inhibitors in bovine lung and pancreas during development.
Wilusz T; Wilimowska-Pelc A; Mejbaum-Katzenellenbogen W
Acta Biochim Pol; 1976; 23(2-3):269-75. PubMed ID: 9760
[TBL] [Abstract][Full Text] [Related]
29. Energy embedding of trypsin inhibitor.
Crippen GM
Biopolymers; 1982 Oct; 21(10):1933-43. PubMed ID: 7171722
[No Abstract] [Full Text] [Related]
30. Conformational stability of porcine-pancreatic secretory trypsin inhibitors (Kazal inhibitors).
Menegatti E; Tomatis R; Guarneri M; Scatturin A
Int J Pept Protein Res; 1981 Apr; 17(4):454-9. PubMed ID: 7309349
[No Abstract] [Full Text] [Related]
31. The role of proline residues in the folding kinetics of the bovine pancreatic trypsin inhibitor derivative RCAM(14-38).
Jullien M; Baldwin RL
J Mol Biol; 1981 Jan; 145(1):265-80. PubMed ID: 7265200
[No Abstract] [Full Text] [Related]
32. Preliminary crystallographic data for the structure of the complex between Kazal trypsin inhibitor and trypsinogen.
Bolognesi M; Coda A; Guarneri M; Menegatti E
J Mol Biol; 1981 Jan; 145(3):603-5. PubMed ID: 7265215
[No Abstract] [Full Text] [Related]
33. Structure-function relationship for Kunitz and Kazal type trypsin inhibitors.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Antonini E
Farmaco Sci; 1983 Dec; 38(12):978-97. PubMed ID: 6365586
[No Abstract] [Full Text] [Related]
34. A model for the association of bovine pancreatic trypsin inhibitor with chymotrypsin and trypsin.
Blow DM; Wright CS; Kukla D; Rühlmann A; Steigemann W; Huber R
J Mol Biol; 1972 Aug; 69(1):137-44. PubMed ID: 4672197
[No Abstract] [Full Text] [Related]
35. Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment.
Gelin BR; Karplus M
Biochemistry; 1979 Apr; 18(7):1256-68. PubMed ID: 427111
[TBL] [Abstract][Full Text] [Related]
36. Isolation and partial characterization of the pancreatic secretory trypsin inhibitor in the rat.
Marks WH; Ohlsson K
Biochim Biophys Acta; 1982 Jul; 717(1):91-7. PubMed ID: 7104395
[TBL] [Abstract][Full Text] [Related]
37. pH dependence of tritium exchange with the C-2 protons of the histidines in bovine trypsin.
Krieger M; Koeppe RE; Stroud RM
Biochemistry; 1976 Aug; 15(16):3458-64. PubMed ID: 8090
[TBL] [Abstract][Full Text] [Related]
38. A nuclear magnetic resonance study of bovine pancreatic trypsin inhibitor. Tyrosine titrations and backbone NH groups.
Karplus S; Snyder GH; Sykes BD
Biochemistry; 1973 Mar; 12(7):1323-9. PubMed ID: 4735299
[No Abstract] [Full Text] [Related]
39. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.
Huber R; Kukla D; Bode W; Schwager P; Bartels K; Deisenhofer J; Steigemann W
J Mol Biol; 1974 Oct; 89(1):73-101. PubMed ID: 4475115
[No Abstract] [Full Text] [Related]
40. Equilibrium folding and unfolding pathways for a model protein.
Miyazawa S; Jernigan RL
Biopolymers; 1982 Jul; 21(7):1333-63. PubMed ID: 7115893
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
